{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:42:47Z","timestamp":1777430567792,"version":"3.51.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"DOI":"10.1186\/s13018-025-06300-2","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T12:43:58Z","timestamp":1759927438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exenatide, a glucagon-like peptide-1 receptor agonist, may negatively impact bone healing in rats: histopathological, biochemical, and in silico findings"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6109-8425","authenticated-orcid":false,"given":"Fatih","family":"Ugur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2003-6337","authenticated-orcid":false,"given":"Ibrahim","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6340-5441","authenticated-orcid":false,"given":"Ersin","family":"Guner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4074-7024","authenticated-orcid":false,"given":"Mehmet","family":"Albayrak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3656-6140","authenticated-orcid":false,"given":"Recep","family":"Taskin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2170-0300","authenticated-orcid":false,"given":"Nurtac","family":"Sarikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3062-5856","authenticated-orcid":false,"given":"Mehmet Akif","family":"Bildirici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5796-5298","authenticated-orcid":false,"given":"Ayse Basak","family":"Dellalbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2186-5305","authenticated-orcid":false,"given":"Candemir","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"6300_CR1","doi-asserted-by":"publisher","first-page":"e670","DOI":"10.1016\/S2665-9913(23)00232-1","volume":"5","author":"TK Gill","year":"2023","unstructured":"Gill TK, et al. Global, regional, and national burden of other musculoskeletal disorders, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5:e670\u201382. https:\/\/doi.org\/10.1016\/S2665-9913(23)00232-1.","journal-title":"Lancet Rheumatol"},{"issue":"Suppl 2","key":"6300_CR2","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.injury.2020.11.029","volume":"52","author":"JA Nicholson","year":"2021","unstructured":"Nicholson JA, Makaram N, Simpson A, Keating JF. Fracture nonunion in long bones: a literature review of risk factors and surgical management. Injury. 2021;52(Suppl 2):S3\u201311.","journal-title":"Injury"},{"key":"6300_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bone.2017.12.027","volume":"108","author":"C Liu","year":"2018","unstructured":"Liu C, Carrera R, Flamini V, Kenny L, Cabahug-Zuckerman P, George BM, et al. Effects of mechanical loading on cortical defect repair using a novel mechanobiological model of bone healing. Bone. 2018;108:145\u201355.","journal-title":"Bone"},{"key":"6300_CR4","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1007\/s11999-016-5159-7","volume":"475","author":"DA Behrends","year":"2017","unstructured":"Behrends DA, Hui D, Gao C, Awlia A, Al-Saran Y, Li A, et al. Defective bone repair in c57bl6 mice with acute systemic inflammation. Clin Orthop Relat Res. 2017;475:906\u201316.","journal-title":"Clin Orthop Relat Res"},{"key":"6300_CR5","first-page":"401","volume":"42","author":"NE Foster","year":"2003","unstructured":"Foster NE, Pincus T, Underwood MR, Vogel S, Breen A, Harding G. Understanding the process of care for musculoskeletal conditions\u2014Why a biomedical approach is inadequate. Rheumatology. 2003;42:401\u20134.","journal-title":"Rheumatology"},{"key":"6300_CR6","first-page":"1","volume-title":"Handbook of medical and health sciences in developing countries","author":"YM Al-Worafi","year":"2024","unstructured":"Al-Worafi YM. Musculoskeletal diseases: causes and risk factors in developing countries. In: Al-Worafi YM, editor. Handbook of medical and health sciences in developing countries. Cham: Springer; 2024. p. 1\u201321."},{"key":"6300_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/bjsports-2018-099878","volume":"54","author":"I Lin","year":"2020","unstructured":"Lin I, Wiles L, Waller R, Goucke R, Nagree Y, Gibberd M, et al. What does best practice care for musculoskeletal pain look like? Eleven consistent recommendations from high-quality clinical practice guidelines: systematic review. Br J Sports Med. 2020;54:79\u201386. https:\/\/doi.org\/10.1136\/bjsports-2018-099878.","journal-title":"Br J Sports Med"},{"key":"6300_CR8","unstructured":"Connelly LB, Woolf A, Brooks P. Cost-effectiveness of interventions for musculoskeletal conditions. In: Jamison DT, Breman JG, Measham AR, et al., editors. Disease control priorities in developing countries. 2nd ed. Washington DC: The International Bank for Reconstruction and Development\/The World Bank; 2006. Chapter 51. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK11713\/. Co-published by Oxford University Press, New York."},{"key":"6300_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.arr.2017.12.006","volume":"42","author":"M Varela-Eirin","year":"2018","unstructured":"Varela-Eirin M, Loureiro J, Fonseca E, Corrochano S, Caeiro JR, Collado M, et al. Cartilage regeneration and aging: targeting cellular plasticity in osteoarthritis. Ageing Res Rev. 2018;42:56\u201371. https:\/\/doi.org\/10.1016\/j.arr.2017.12.006.","journal-title":"Ageing Res Rev"},{"key":"6300_CR10","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/jbmr.4902","volume":"38","author":"DK Khajuria","year":"2023","unstructured":"Khajuria DK, Karuppagounder V, Nowak I, Sepulveda DE, Lewis GS, Norbury CC, et al. Cannabidiol and cannabigerol, nonpsychotropic cannabinoids, as analgesics that effectively manage bone fracture pain and promote healing in mice. J Bone Miner Res. 2023;38:1560\u201376. https:\/\/doi.org\/10.1002\/jbmr.4902.","journal-title":"J Bone Miner Res"},{"key":"6300_CR11","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/jbmr.2513","volume":"30","author":"NM Kogan","year":"2015","unstructured":"Kogan NM, Melamed E, Wasserman E, Raphael B, Breuer A, Stok KS, et al. Cannabidiol, a major non-psychotropic cannabis constituent enhances fracture healing and stimulates lysyl hydroxylase activity in osteoblasts. J Bone Miner Res. 2015;30:1905\u201313. https:\/\/doi.org\/10.1002\/jbmr.2513.","journal-title":"J Bone Miner Res"},{"key":"6300_CR12","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s11033-025-10648-3","volume":"52","author":"W Zhou","year":"2025","unstructured":"Zhou W, Huang W, Shen X, Huang K, Tian R, Yuan Y, et al. Activation of GLP-1 receptors enhances the osteogenic differentiation process of STRO-1-positive BMSCs. Mol Biol Rep. 2025;52:559. https:\/\/doi.org\/10.1007\/s11033-025-10648-3.","journal-title":"Mol Biol Rep"},{"key":"6300_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.stemcr.2016.02.002","volume":"6","author":"J Meng","year":"2016","unstructured":"Meng J, Ma X, Wang N, Jia M, Bi L, Wang Y, et al. Activation of GLP-1 receptor promotes bone marrow stromal cell osteogenic differentiation through \u03b2-catenin. Stem Cell Rep. 2016;6:579\u201391. https:\/\/doi.org\/10.1016\/j.stemcr.2016.02.002.","journal-title":"Stem Cell Rep"},{"key":"6300_CR14","doi-asserted-by":"publisher","first-page":"170974","DOI":"10.1016\/j.peptides.2023.170974","volume":"163","author":"S Zhai","year":"2023","unstructured":"Zhai S, Liu C, Vimalraj S, Subramanian R, Abullais SS, Arora S, et al. Glucagon-like peptide-1 receptor promotes osteoblast differentiation of dental pulp stem cells and bone formation in a zebrafish scale regeneration model. Peptides. 2023;163:170974. https:\/\/doi.org\/10.1016\/j.peptides.2023.170974.","journal-title":"Peptides"},{"key":"6300_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/term.1655","volume":"9","author":"G Hulsart-Billstr\u00f6m","year":"2015","unstructured":"Hulsart-Billstr\u00f6m G, Bergman K, Andersson B, Hilborn J, Larsson S, Jonsson KB. A uni-cortical femoral defect model in the rat: evaluation using injectable hyaluronan hydrogel as a carrier for bone morphogenetic protein-2. J Tissue Eng Regen Med. 2015;9:799\u2013807. https:\/\/doi.org\/10.1002\/term.1655.","journal-title":"J Tissue Eng Regen Med"},{"key":"6300_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejr.2019.06.003","volume":"42","author":"OMA Taleb","year":"2020","unstructured":"Taleb OMA, Wissa MY, Nour RKAE, Awad HA, Moussa NM. Potential effectiveness of exenatide in experimentally-induced osteoporosis. Egypt Rheumatol. 2020;42:57\u201362. https:\/\/doi.org\/10.1016\/j.ejr.2019.06.003.","journal-title":"Egypt Rheumatol"},{"key":"6300_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrrheum.2014.164","volume":"11","author":"TA Einhorn","year":"2015","unstructured":"Einhorn TA, Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nat Rev Rheumatol. 2015;11:45\u201354.","journal-title":"Nat Rev Rheumatol"},{"key":"6300_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrrheum.2012.1","volume":"8","author":"C Lutz","year":"2012","unstructured":"Lutz C, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol. 2012;8:133\u201343.","journal-title":"Nat Rev Rheumatol"},{"key":"6300_CR19","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1359\/jbmr.2001.16.6.1004","volume":"16","author":"T Kon","year":"2001","unstructured":"Kon T, Cho TJ, Aizawa T, Yamazaki M, Nooh N, Graves D, et al. Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res. 2001;16:1004\u201314. https:\/\/doi.org\/10.1359\/jbmr.2001.16.6.1004.","journal-title":"J Bone Miner Res"},{"key":"6300_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/jor.1100090310","volume":"9","author":"MH Huo","year":"1991","unstructured":"Huo MH, Troiano NW, Pelker RR, Gundberg CM, Friedlaender GE. The influence of ibuprofen on fracture repair: Biomechanical, biochemical, histologic, and histomorphometric parameters in rats. J Orthop Res. 1991;9:383\u201390. https:\/\/doi.org\/10.1002\/jor.1100090310.","journal-title":"J Orthop Res"},{"key":"6300_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41467-021-27760-0","volume":"13","author":"G Deganutti","year":"2022","unstructured":"Deganutti G, Liang YL, Zhang X, Khoshouei M, Clydesdale L, Belousoff MJ, et al. Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation. Nat Commun. 2022;13:92. https:\/\/doi.org\/10.1038\/s41467-021-27760-0.","journal-title":"Nat Commun"},{"key":"6300_CR22","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/s0969-2126(96)00134-7","volume":"4","author":"JH Naismith","year":"1996","unstructured":"Naismith JH, Devine TQ, Kohno T, Sprang SR. Structures of the extracellular domain of the type I tumor necrosis factor receptor. Structure. 1996;4:1251\u201362. https:\/\/doi.org\/10.1016\/s0969-2126(96)00134-7.","journal-title":"Structure"},{"key":"6300_CR23","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1126\/science.1083901","volume":"300","author":"MJ Boulanger","year":"2003","unstructured":"Boulanger MJ, Chow DC, Brevnova EE, Garcia KC. Hexameric structure and assembly of the interleukin-6\/IL-6 alpha-receptor\/gp130 complex. Science. 2003;300:2101\u20134. https:\/\/doi.org\/10.1126\/science.1083901.","journal-title":"Science"},{"key":"6300_CR24","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1016\/j.injury.2023.08.052","volume":"54","author":"F Migliorini","year":"2023","unstructured":"Migliorini F, Pilone M, Eschweiler J, El Mansy Y, Maffulli N, Schenker H. Pharmacological interventions for fracture healing: a systematic review of randomized controlled trials. Injury. 2023;54:3673\u201382. https:\/\/doi.org\/10.1016\/j.injury.2023.08.052.","journal-title":"Injury"},{"key":"6300_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/bmb\/ldr003","volume":"100","author":"P Martinez de Albornoz","year":"2011","unstructured":"Martinez de Albornoz P, Khanna A, Longo UG, Forriol F, Maffulli N. The evidence of low-intensity pulsed ultrasound for in vitro, animal and human fracture healing. Br Med Bull. 2011;100:39\u201357. https:\/\/doi.org\/10.1093\/bmb\/ldr003.","journal-title":"Br Med Bull"},{"key":"6300_CR26","doi-asserted-by":"publisher","first-page":"7094","DOI":"10.3390\/ijms24087094","volume":"24","author":"M Berni","year":"2023","unstructured":"Berni M, Brancato AM, Torriani C, Bina V, Annunziata S, Cornella E, et al. The role of low-level laser therapy in bone healing: systematic review. Int J Mol Sci. 2023;24:7094. https:\/\/doi.org\/10.3390\/ijms24087094.","journal-title":"Int J Mol Sci"},{"key":"6300_CR27","doi-asserted-by":"publisher","first-page":"7403","DOI":"10.3390\/ijms22147403","volume":"22","author":"L Caliogna","year":"2021","unstructured":"Caliogna L, Medetti M, Bina V, Brancato AM, Castelli A, Jannelli E, et al. Pulsed electromagnetic fields in bone healing: molecular pathways and clinical applications. Int J Mol Sci. 2021;22:7403. https:\/\/doi.org\/10.3390\/ijms22147403.","journal-title":"Int J Mol Sci"},{"key":"6300_CR28","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.2106\/JBJS.G.00686","volume":"90","author":"T Niikura","year":"2008","unstructured":"Niikura T, Sakai Y, Lee SY, Oe K, Iwakura T, Kurosaka M. Intermittent pneumatic compression for treating bone and soft-tissue healing: a systematic review. J Bone Jt Surg Am. 2008;90:1689\u201396. https:\/\/doi.org\/10.2106\/JBJS.G.00686.","journal-title":"J Bone Jt Surg Am"},{"key":"6300_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1186\/s13018-024-05138-4","volume":"19","author":"X Ji","year":"2024","unstructured":"Ji X, Zhao D, Xin Z, Feng H, Huang Z. The predictive value of stress-induced hyperglycemia parameters for delayed healing after tibial fracture post-surgery. J Orthop Surg Res. 2024;19:666. https:\/\/doi.org\/10.1186\/s13018-024-05138-4.","journal-title":"J Orthop Surg Res"},{"key":"6300_CR30","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1186\/s13018-024-05351-1","volume":"19","author":"J Liu","year":"2024","unstructured":"Liu J, Liu TT, Zhang HC, Li C, Wei W, Chao AJ. Effects of Jintiange on the healing of osteoporotic fractures in aged rats. J Orthop Surg Res. 2024;19:828. https:\/\/doi.org\/10.1186\/s13018-024-05351-1.","journal-title":"J Orthop Surg Res"},{"key":"6300_CR31","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1186\/s13018-024-05291-w","volume":"19","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Wang L, Zhang F, Jing S, Cen M. Functional mechanism and clinical implications of mir-1271-5p in pilon fracture healing processes. J Orthop Surg Res. 2024;19:782. https:\/\/doi.org\/10.1186\/s13018-024-05291-w.","journal-title":"J Orthop Surg Res"},{"key":"6300_CR32","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1186\/s13018-024-05226-5","volume":"19","author":"X Wu","year":"2024","unstructured":"Wu X, Shen T, Ji W, Huang M, Sima J, Li J, et al. LncRNA CASC11 regulates the progress of delayed fracture healing via sponging miR-150-3p. J Orthop Surg Res. 2024;19:757. https:\/\/doi.org\/10.1186\/s13018-024-05226-5.","journal-title":"J Orthop Surg Res"},{"key":"6300_CR33","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s13018-024-04998-0","volume":"19","author":"Y Li","year":"2024","unstructured":"Li Y, Sun Y, Ma K, Wang S, Wang Z, Huang L. Functional mechanism and clinical implications of LINC00339 in delayed fracture healing. J Orthop Surg Res. 2024;19:511. https:\/\/doi.org\/10.1186\/s13018-024-04998-0.","journal-title":"J Orthop Surg Res"},{"key":"6300_CR34","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/jbmr.1898","volume":"28","author":"X Ma","year":"2013","unstructured":"Ma X, Meng J, Jia M, Bi L, Zhou Y, Wang Y, et al. Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats. J Bone Miner Res. 2013;28:1641\u201352. https:\/\/doi.org\/10.1002\/jbmr.1898.","journal-title":"J Bone Miner Res"},{"key":"6300_CR35","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bone.2015.08.006","volume":"81","author":"M Pereira","year":"2015","unstructured":"Pereira M, Jeyabalan J, J\u00f8rgensen CS, Hopkinson M, Al-Jazzar A, Roux JP, et al. Chronic administration of glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice. Bone. 2015;81:459\u201367. https:\/\/doi.org\/10.1016\/j.bone.2015.08.006.","journal-title":"Bone"},{"key":"6300_CR36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s12020-015-0667-x","volume":"51","author":"HX Sun","year":"2016","unstructured":"Sun HX, Lu N, Liu DM, Zhao L, Sun LH, Zhao HY, et al. The bone-preserving effects of exendin-4 in ovariectomized rats. Endocrine. 2016;51:323\u201332. https:\/\/doi.org\/10.1007\/s12020-015-0667-x.","journal-title":"Endocrine"},{"key":"6300_CR37","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fendo.2017.00327","volume":"8","author":"M Pereira","year":"2017","unstructured":"Pereira M, Gohin S, Roux JP, Fisher A, Cleasby ME, Mabilleau G, et al. Exenatide improves bone quality in a murine model of genetically inherited type 2 diabetes mellitus. Front Endocrinol. 2017;8:327. https:\/\/doi.org\/10.3389\/fendo.2017.00327.","journal-title":"Front Endocrinol"},{"key":"6300_CR38","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/1753-0407.12102","volume":"6","author":"G Mabilleau","year":"2014","unstructured":"Mabilleau G, Mieczkowska A, Chappard D. Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials. J Diabetes. 2014;6:260\u20136. https:\/\/doi.org\/10.1111\/1753-0407.12102.","journal-title":"J Diabetes"},{"key":"6300_CR39","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s00404-018-4776-7","volume":"297","author":"E Eminov","year":"2018","unstructured":"Eminov E, Hortu I, Akman L, Erbas O, Yavasoglu A, Cirpan T. Exenatide preserves trabecular bone microarchitecture in experimental ovariectomized rat model. Arch Gynecol Obstet. 2018;297:1587\u201393. https:\/\/doi.org\/10.1007\/s00404-018-4776-7.","journal-title":"Arch Gynecol Obstet"},{"key":"6300_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fendo.2019.00051","volume":"10","author":"SA Mansur","year":"2019","unstructured":"Mansur SA, Mieczkowska A, Flatt PR, Chappard D, Irwin N, Mabilleau G. The GLP-1 receptor agonist exenatide ameliorates bone composition and tissue material properties in high fat fed diabetic mice. Front Endocrinol. 2019;10:51. https:\/\/doi.org\/10.3389\/fendo.2019.00051.","journal-title":"Front Endocrinol"},{"key":"6300_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3361309","author":"TT Cai","year":"2021","unstructured":"Cai TT, Li HQ, Jiang LL, Wang HY, Luo MH, Su XF, et al. Effects of GLP-1 receptor agonists on bone mineral density in patients with type 2 diabetes mellitus: a 52-week clinical study. BioMed Res Int. 2021. https:\/\/doi.org\/10.1155\/2021\/3361309.","journal-title":"BioMed Res Int"},{"key":"6300_CR42","doi-asserted-by":"publisher","first-page":"112125","DOI":"10.1016\/j.diabres.2025.112125","volume":"223","author":"E Maddaloni","year":"2025","unstructured":"Maddaloni E, Coleman RL, Holman RR. Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: insights from an EXSCEL post-hoc analysis. Diabetes Res Clin Pract. 2025;223:112125. https:\/\/doi.org\/10.1016\/j.diabres.2025.112125.","journal-title":"Diabetes Res Clin Pract"},{"key":"6300_CR43","doi-asserted-by":"publisher","first-page":"e35394","DOI":"10.1097\/MD.0000000000035394","volume":"102","author":"OZ Akyay","year":"2023","unstructured":"Akyay OZ, Canturk Z, Selek A, Cetinarslan B, Tarkun \u0130, Cakmak Y, et al. The effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus. Medicine. 2023;102:e35394. https:\/\/doi.org\/10.1097\/MD.0000000000035394.","journal-title":"Medicine"},{"key":"6300_CR44","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00592-024-02415-w","volume":"62","author":"Y Xiao","year":"2025","unstructured":"Xiao Y, Zhou M, Xiao W. Fracture events associated with GLP-1 receptor agonists in FDA adverse events reporting system. Acta Diabetol. 2025;62:1009\u201310021. https:\/\/doi.org\/10.1007\/s00592-024-02415-w.","journal-title":"Acta Diabetol"},{"key":"6300_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s12020-014-0361-4","volume":"48","author":"B Su","year":"2015","unstructured":"Su B, Sheng H, Zhang M, Bu L, Yang P, Li L, et al. Risk of bone fractures associated with glucagon-like peptide-1 receptor agonists\u2019 treatment: a meta-analysis of randomized controlled trials. Endocrine. 2015;48:107\u201315. https:\/\/doi.org\/10.1007\/s12020-014-0361-4.","journal-title":"Endocrine"},{"key":"6300_CR46","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fendo.2017.00098","volume":"8","author":"C Zhao","year":"2017","unstructured":"Zhao C, Liang J, Yang Y, Yu M, Qu X. The impact of glucagon-like peptide-1 on bone metabolism and its possible mechanisms. Front Endocrinol. 2017;8:98. https:\/\/doi.org\/10.3389\/fendo.2017.00098.","journal-title":"Front Endocrinol"},{"key":"6300_CR47","doi-asserted-by":"publisher","first-page":"112199","DOI":"10.1016\/j.diabres.2025.112199","volume":"224","author":"M Wang","year":"2025","unstructured":"Wang M, Li Y, Sui F. Letter to \u201cRisk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: Insights from an EXSCEL post-hoc analysis.\u201d Diabetes Res Clin Pract. 2025;224:112199. https:\/\/doi.org\/10.1016\/j.diabres.2025.112199.","journal-title":"Diabetes Res Clin Pract"},{"key":"6300_CR48","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/jor.23754","volume":"36","author":"AI Hussein","year":"2018","unstructured":"Hussein AI, Mancini C, Lybrand KE, Cooke ME, Matheny HE, Hogue BL, et al. Serum proteomic assessment of the progression of fracture healing. J Orthop Res. 2018;36:1153\u201363. https:\/\/doi.org\/10.1002\/jor.23754.","journal-title":"J Orthop Res"},{"key":"6300_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jare.2022.08.019","volume":"49","author":"XQ Zheng","year":"2023","unstructured":"Zheng XQ, Huang J, Lin JL, Song CL. Pathophysiological mechanism of acute bone loss after fracture. J Adv Res. 2023;49:63\u201380. https:\/\/doi.org\/10.1016\/j.jare.2022.08.019.","journal-title":"J Adv Res"},{"issue":"1","key":"6300_CR50","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1038\/s41598-017-07511-2","volume":"7","author":"V Fischer","year":"2017","unstructured":"Fischer V, Haffner-Luntzer M, Prystaz K, Vom Scheidt A, Busse B, Schinke T, et al. Calcium and vitamin D deficiency marginally impairs fracture healing but aggravates posttraumatic bone loss in osteoporotic mice. Sci Rep. 2017;7(1):7223. https:\/\/doi.org\/10.1038\/s41598-017-07511-2.","journal-title":"Sci Rep"},{"key":"6300_CR51","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3390\/biom11040506","volume":"11","author":"\u017b Ciosek","year":"2021","unstructured":"Ciosek \u017b, Kot K, Kosik-Bogacka D, \u0141anocha-Arendarczyk N, Rotter I. The effects of calcium, magnesium, phosphorus, fluoride, and lead on bone tissue. Biomolecules. 2021;11:506. https:\/\/doi.org\/10.3390\/biom11040506.","journal-title":"Biomolecules"},{"key":"6300_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/s0169-6009(08)80187-0","volume":"27","author":"A Sabokbar","year":"1994","unstructured":"Sabokbar A, Millett PJ, Myer B, Rushton N. A rapid, quantitative assay for measuring alkaline phosphatase activity in osteoblastic cells in vitro. Bone Miner. 1994;27:57\u201367. https:\/\/doi.org\/10.1016\/s0169-6009(08)80187-0.","journal-title":"Bone Miner"},{"key":"6300_CR53","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0020-1383(02)00380-7","volume":"34","author":"T Taniguchi","year":"2003","unstructured":"Taniguchi T, Tomoko M, Shindo H. Changes of serum levels of osteocalcin, alkaline phosphatase, IGF-I and IGF-binding protein-3 during fracture healing. Injury. 2003;34:477\u20139.","journal-title":"Injury"},{"key":"6300_CR54","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12891-022-05438-y","volume":"23","author":"J Shu","year":"2022","unstructured":"Shu J, Tan A, Li Y, Huang H, Yang J. The correlation between serum total alkaline phosphatase and bone mineral density in young adults. BMC Musculoskelet Disord. 2022;23:467. https:\/\/doi.org\/10.1186\/s12891-022-05438-y.","journal-title":"BMC Musculoskelet Disord"},{"key":"6300_CR55","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.21037\/apm-20-218","volume":"10","author":"Z Chen","year":"2021","unstructured":"Chen Z, Xie L, Xu J, Lin X, Ye J, Shao R, et al. Changes in alkaline phosphatase, calcium, C-reactive protein, D-dimer, phosphorus, and hemoglobin in elderly osteoporotic hip fracture patients. Ann Palliat Med. 2021;10:1079\u201388. https:\/\/doi.org\/10.21037\/apm-20-218.","journal-title":"Ann Palliat Med"},{"key":"6300_CR56","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.3390\/ijms23031481","volume":"23","author":"H Kitaura","year":"2022","unstructured":"Kitaura H, Marahleh A, Ohori F, Noguchi T, Nara Y, Pramusita A, et al. Role of the interaction of tumor necrosis factor-\u03b1 and tumor necrosis factor receptors 1 and 2 in bone-related cells. Int J Mol Sci. 2022;23:1481. https:\/\/doi.org\/10.3390\/ijms23031481.","journal-title":"Int J Mol Sci"},{"key":"6300_CR57","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.2147\/JIR.S507269","volume":"18","author":"W Zhao","year":"2025","unstructured":"Zhao W, Li J, Su T, Wang C, Fu Y, Li C, et al. Osteoclast activation and inflammatory bone diseases: focusing on receptors in osteoclasts. J Inflamm Res. 2025;18:3201\u201313. https:\/\/doi.org\/10.2147\/JIR.S507269.","journal-title":"J Inflamm Res"},{"key":"6300_CR58","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/jbm.a.34058","volume":"100","author":"PM Mountziaris","year":"2012","unstructured":"Mountziaris PM, Tzouanas SN, Mikos AG. The interplay of bone-like extracellular matrix and TNF-\u03b1 signaling on in vitro osteogenic differentiation of mesenchymal stem cells. J Biomed Mater Res A. 2012;100:1097\u2013106. https:\/\/doi.org\/10.1002\/jbm.a.34058.","journal-title":"J Biomed Mater Res A"},{"key":"6300_CR59","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.3892\/mmr.2018.8698","volume":"17","author":"G Luo","year":"2018","unstructured":"Luo G, Li F, Li X, Wang ZG, Zhang B. TNF \u03b1 and RANKL promote osteoclastogenesis by upregulating RANK via the NF \u03baB pathway. Mol Med Rep. 2018;17:6605\u201311. https:\/\/doi.org\/10.3892\/mmr.2018.8698.","journal-title":"Mol Med Rep"},{"key":"6300_CR60","doi-asserted-by":"publisher","DOI":"10.1097\/SHK.0000000000002615","author":"V Fischer","year":"2025","unstructured":"Fischer V, K\u00fcppers O, Steppe L, Kr\u00fcger BT, Hidalgo J, Haffner-Luntzer M, et al. Physiological fracture healing is unaffected by neutrophil-derived IL-6 or IL-6R signaling in mice. Shock. 2025. https:\/\/doi.org\/10.1097\/SHK.0000000000002615.","journal-title":"Shock"},{"key":"6300_CR61","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00210-018-1483-7","volume":"391","author":"K Kaiser","year":"2018","unstructured":"Kaiser K, Prystaz K, Vikman A, Haffner-Luntzer M, Bergdolt S, Strauss G, et al. Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe trauma. Naunyn Schmiedebergs Arch Pharmacol. 2018;391:523\u201336. https:\/\/doi.org\/10.1007\/s00210-018-1483-7.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"6300_CR62","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11010-017-2967-3","volume":"430","author":"G Pesic","year":"2017","unstructured":"Pesic G, Jeremic J, Nikolic T, Zivkovic V, Srejovic I, Vranic A, et al. Interleukin-6 as possible early marker of stress response after femoral fracture. Mol Cell Biochem. 2017;430:191\u20139. https:\/\/doi.org\/10.1007\/s11010-017-2967-3.","journal-title":"Mol Cell Biochem"},{"key":"6300_CR63","doi-asserted-by":"publisher","first-page":"e1008586","DOI":"10.1371\/journal.pgen.1008586","volume":"16","author":"T Moriishi","year":"2020","unstructured":"Moriishi T, Ozasa R, Ishimoto T, Nakano T, Hasegawa T, Miyazaki T, et al. Osteocalcin is necessary for the alignment of apatite crystallites, but not glucose metabolism, testosterone synthesis, or muscle mass. PLoS Genet. 2020;16:e1008586. https:\/\/doi.org\/10.1371\/journal.pgen.1008586.","journal-title":"PLoS Genet"},{"key":"6300_CR64","doi-asserted-by":"publisher","first-page":"e1008714","DOI":"10.1371\/journal.pgen.1008714","volume":"16","author":"SC Manolagas","year":"2020","unstructured":"Manolagas SC. Osteocalcin promotes bone mineralization but is not a hormone. PLoS Genet. 2020;16:e1008714. https:\/\/doi.org\/10.1371\/journal.pgen.1008714.","journal-title":"PLoS Genet"},{"key":"6300_CR65","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00109-024-02418-8","volume":"102","author":"M Martiniakova","year":"2024","unstructured":"Martiniakova M, Biro R, Kovacova V, Babikova M, Zemanova N, Mondockova V, et al. Current knowledge of bone-derived factor osteocalcin: its role in the management and treatment of diabetes mellitus, osteoporosis, osteopetrosis, and inflammatory joint diseases. J Mol Med. 2024;102:435\u201352. https:\/\/doi.org\/10.1007\/s00109-024-02418-8.","journal-title":"J Mol Med"},{"issue":"1","key":"6300_CR66","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40729-021-00327-w","volume":"7","author":"E Chatzipetros","year":"2021","unstructured":"Chatzipetros E, Damaskos S, Tosios KI, Christopoulos P, Donta C, Kalogirou EM, et al. The effect of nano-hydroxyapatite\/chitosan scaffolds on rat calvarial defects for bone regeneration. Int J Implant Dent. 2021;7(1):40. https:\/\/doi.org\/10.1186\/s40729-021-00327-w.","journal-title":"Int J Implant Dent"},{"key":"6300_CR67","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.26355\/eurrev_202204_28630","volume":"26","author":"I Yilmaz","year":"2022","unstructured":"Yilmaz I, Karaarslan N. Examining the effects of HMG-CoA reductase inhibitors on anabolic and catabolic signaling pathway proteins associated with degenerative disc disease. Eur Rev Med Pharmacol Sci. 2022;26:2990\u20133000. https:\/\/doi.org\/10.26355\/eurrev_202204_28630.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6300_CR68","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.26355\/eurrev_202207_29207","volume":"26","author":"I Yilmaz","year":"2022","unstructured":"Yilmaz I, Akalan H, Oznam K, Karaarslan N, Yasar Sirin D, Ozbek H. Does oseltamivir protect human chondrocyte and nucleus pulposus cells from degeneration by inhibiting senescence and proinflammation mediated by the NLRP3 inflammasome and NF-\u03baB? Eur Rev Med Pharmacol Sci. 2022;26:4816\u201327. https:\/\/doi.org\/10.26355\/eurrev_202207_29207.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6300_CR69","first-page":"112","volume":"31","author":"I Yilmaz","year":"2021","unstructured":"Yilmaz I, Karaarslan N, Ozbek H. Practical performance of hippocampal tissue resection in rats in pharmacomolecular research. Turk Neurosurg. 2021;31:112\u20138.","journal-title":"Turk Neurosurg"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06300-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-025-06300-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-025-06300-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T12:44:00Z","timestamp":1759927440000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-025-06300-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6300"],"URL":"https:\/\/doi.org\/10.1186\/s13018-025-06300-2","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"3 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval to use live mammal subjects in the research was obtained from the Kastamonu University Experimental Animals Unit (Date: 10.01.2025, approval number: 2025\/1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"883"}}